Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
J Infect. 2013 Jan;66(1):67-74. doi: 10.1016/j.jinf.2012.08.014. Epub 2012 Aug 30.
To examine the prevalence and distribution among racial/ethnic groups of polyomavirus SV40 antibodies in women in Houston, Texas.
Women in three different cohorts reflecting the evolving demographics of Houston were evaluated for frequency of SV40 antibodies using a plaque-reduction neutralization assay.
Women in cohort A (enrolled 1972-1973) were 68% (145/212) African-American and 32% Caucasian; the overall frequency of SV40 neutralizing antibodies was 7%. Women in cohort B (enrolled 1975-1977) were Caucasian with an overall frequency of SV40 neutralizing antibodies of 18% (37/211). Women in cohort C (enrolled 1993-1995) were 50% (199/400) African-American, 25% Caucasian, and 25% Hispanic; the overall frequency of SV40 neutralizing antibodies was 10%. Logistic regression analysis for cohort A showed no difference in SV40 neutralizing antibodies with respect to race/ethnicity, pregnancy status, number of previous pregnancies, or history of sexually transmitted diseases. For cohort C, race/ethnicity was identified as a significant factor associated with SV40 neutralizing antibodies, with Hispanics having a seroprevalence of 23% compared to 5-6% in the other two groups (p = 0.01).
A significantly higher SV40 seroprevalence was found among Hispanics than other racial/ethnic groups in the city of Houston. Findings are compatible with a model that certain population groups potentially exposed to SV40-contaminated oral poliovaccines have maintained cycles of SV40 infections.
检测德克萨斯州休斯顿市不同种族/族裔女性中多瘤病毒 SV40 抗体的流行率和分布情况。
使用空斑减少中和试验评估了三个不同队列的女性 SV40 抗体的频率,这些队列反映了休斯顿人口统计学的演变。
队列 A(1972-1973 年入组)的女性 68%(145/212)为非裔美国人,32%为白种人;SV40 中和抗体的总体频率为 7%。队列 B(1975-1977 年入组)的女性均为白种人,SV40 中和抗体的总体频率为 18%(37/211)。队列 C(1993-1995 年入组)的女性 50%(199/400)为非裔美国人,25%为白种人,25%为西班牙裔;SV40 中和抗体的总体频率为 10%。对队列 A 进行逻辑回归分析显示,SV40 中和抗体与种族/民族、妊娠状况、既往妊娠次数或性传播疾病史无关。对于队列 C,种族/民族被确定为与 SV40 中和抗体相关的重要因素,与其他两个群体(p=0.01)相比,西班牙裔的血清阳性率为 23%,而其他两个群体为 5-6%。
与休斯顿市的其他种族/族裔群体相比,西班牙裔人群中 SV40 的血清阳性率显著更高。这些发现与某些人群群体可能接触到受 SV40 污染的口服脊髓灰质炎疫苗,并维持 SV40 感染循环的模型一致。